Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 9.13 USD -2.56% Market Closed
Market Cap: 499.2m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+151%
Revenue
Forecast
+119%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

ZVRA Price Targets Summary
Zevra Therapeutics Inc

Wall Street analysts forecast ZVRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZVRA is 22.88 USD with a low forecast of 19.19 USD and a high forecast of 26.25 USD.

ZVRA Lowest Forecast
Wall Street Target
19.19 USD
110% Upside
ZVRA Average Forecast
Wall Street Target
22.88 USD
151% Upside
ZVRA Highest Forecast
Wall Street Target
26.25 USD
188% Upside
Lowest
Price Target
19.19 USD
110% Upside
Average
Price Target
22.88 USD
151% Upside
Highest
Price Target
26.25 USD
188% Upside
Zevra Therapeutics Inc Competitors:
Price Targets
Z
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
16% Upside
1177
Sino Biopharmaceutical Ltd
8% Downside
VENUSREM
Venus Remedies Ltd
27% Downside
069620
Daewoong Pharma
29% Upside
Z
300357
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
16% Upside
1177
Sino Biopharmaceutical Ltd
8% Downside
VENUSREM
Venus Remedies Ltd
27% Downside
069620
Daewoong Pharma
29% Upside
P
603566
Pulike Biological Engineering Inc
12% Upside
4886
ASKA Pharmaceutical Holdings Co Ltd
11% Upside
MRK
Merck & Co Inc
28% Upside
185750
Chong Kun Dang Pharmaceutical Corp
47% Upside

Revenue
Forecast

Revenue Estimate
Zevra Therapeutics Inc

The compound annual growth rate of Zevra Therapeutics Inc's revenue for the next 3 years is 119%.

N/A
Past Growth
119%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Zevra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Zevra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
What are analyst estimates?

See Also

Summary
ZVRA intrinsic value, competitors valuation, and company profile.
DCF Valuation
ZVRA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ZVRA stock valuation using valuation multiples.
Wall Street Estimates
ZVRA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ZVRA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZVRA's stock price target?
Price Target
22.88 USD

According to Wall Street analysts, the average 1-year price target for ZVRA is 22.88 USD with a low forecast of 19.19 USD and a high forecast of 26.25 USD.

What is Zevra Therapeutics Inc's Revenue forecast?
Projected CAGR
119%

The compound annual growth rate of Zevra Therapeutics Inc's revenue for the next 3 years is 119%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.